Boston Scientific's heart stent wins approval in Canada

04/26/2012 | Reuters

Boston Scientific has received approval from Health Canada for its PROMUS Element Plus stent and plans to start marketing the device there immediately. The device, designed to treat patients with coronary artery disease, improves on the company's existing stent with a better-performing catheter delivery system.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT